References
- Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest, 2004;114:5-14. https://doi.org/10.1172/JCI200422353
- Nishida M, Fujimoto S, Toiyama K, Sato H, Hamaoka K. Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice. Biochem Biophys Res Commun 2004;324:341-7. https://doi.org/10.1016/j.bbrc.2004.09.051
- Joannidis M, Forni LG. Clinical review: timing of renal replacement therapy. Crit Care 2011;15:223. https://doi.org/10.1186/cc10109
- Garcovich M1, Zocco MA, Gasbarrini A. Clinical use of albumin in hepatology. Blood Transfus 2009;7:268-77.
- Cadwallader AB1, de la Torre X, Tieri A, Botre F. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis. Br J Pharmacol 2010;161:1-16. https://doi.org/10.1111/j.1476-5381.2010.00789.x
- Needham E, Management of acute renal failure. Am Fam Physician 2005;72:1739-46.
- Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004;15:1794-804. https://doi.org/10.1097/01.ASN.0000128974.07460.34
- Cimino GD, Pan CX, Henderson PT. Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer. Bioanalysis 2013;5:369-91. https://doi.org/10.4155/bio.12.325
- Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev 2012;64:706-21. https://doi.org/10.1124/pr.111.005637
- Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99:3838-43. https://doi.org/10.1182/blood.V99.10.3838
- Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003;14:1188-99. https://doi.org/10.1097/01.ASN.0000061595.28546.A0
- Chhabra P, Brayman KL. The use of stem cells in kidney disease. Curr Opin Organ Transplant 2009;14:72-8. https://doi.org/10.1097/MOT.0b013e328320d2f5
- Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003;5:362-9. https://doi.org/10.1080/14653240310003026
- Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-95. https://doi.org/10.1091/mbc.e02-02-0105
- Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008;45:115-20. https://doi.org/10.1016/j.ymeth.2008.03.006
- Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007;18:2486-96. https://doi.org/10.1681/ASN.2007020140
- Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, et al. Identification and kinetics of leukocytes after severe ischemia/reperfusion renal injury. Nephrol Dial Transplant 2000;15:1562-74. https://doi.org/10.1093/ndt/15.10.1562
- Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001;281:F887-F899. https://doi.org/10.1152/ajprenal.00050.2001
- Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001;60:804-17. https://doi.org/10.1046/j.1523-1755.2001.060002804.x
- Greene SN, Ramos-Vara JA, Craig BA, Hooser SB, Anderson C, Fourez LM, et al. Effects of cyclooxygenase inhibitor treatment on the renal toxicity of cisplatin in rats. Cancer Chemother Pharmacol 2010;65:549-56. https://doi.org/10.1007/s00280-009-1061-2
- Suddek GM. Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals. Cancer Chemother Pharmacol 2011;67:1035-44. https://doi.org/10.1007/s00280-010-1402-1
- Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008;59:311-25. https://doi.org/10.1146/annurev.med.59.061506.154239
- Thomas J, Liu F, Link DC. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol 2002;9:183-9. https://doi.org/10.1097/00062752-200205000-00002
- Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-84. https://doi.org/10.1002/jcb.20886